News
Home>News>Industry News

Electrophysiology Devices Market, By Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories & Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT)

2019-12-11 10:30:29

The global electrophysiology devices market size was USD 5 billion in 2018 and is projected to reach USD 11 billion by 2026, exhibiting a CAGR of 11% during the forecast period.


Today, electrophysiology devices are an important segment in the healthcare industry. Electrophysiology devices are mainly used in the diagnosis and treatment of cardiac arrhythmias or abnormal heartbeats. Increasing adoption of electrophysiology devices in the diagnosis and treatment of cardiovascular diseases such as atrial fibrillation, and increasing demand for cardiac rhythm management devices for continuous monitoring are some factors anticipated to drive the growth of the global electrophysiology devices market during the forecast period.


Increasing prevalence of heart failure (HF) and cardiac arrest cases, due to smoking and excessive alcohol consumption, have created a high demand for electrophysiology devices. The growing demand for the product will have a positive influence on the growth of the market. According to an article published by the US National Library of Medicine National Institutes of Health, sudden cardiac death (SCD) occurs in approximately 40 cases per 100,000 people in Asia Pacific annually.

Based on type, the electrophysiology devices market is segmented into ablation catheters, diagnostic catheters, mapping systems, accessories and others. Ablation catheters segment is anticipated to hold a significant electrophysiology devices market share and is expected to grow at a significant CAGR during the forecast period.


The ablation catheters segment is primarily driven by the increase in the use of the ablation procedures for the treatment of atrial fibrillation. According to the European Heart Rhythm Association (EHRA) survey, more than 50,000 catheter ablations are performed every year in Europe. The rising prevalence of atrial fibrillation is one of the major factors propelling the demand for the ablation catheters across the world.

North America generated a revenue of USD 1.65 billion in 2018 and is anticipated to emerge as a dominant region in the electrophysiology devices market during the forecast period. The dominance is attributable to the growing prevalence of heart failure (HF), cardiac arrest, and cardiac arrhythmia in this region due to an unhealthy lifestyle, smoking and alcohol consumption. Presence of favorable reimbursement policies in the region is also one of the major elements expected to drive the market growth during the forecast period.


The electrophysiology devices market in Asia Pacific is projected to grow at a significant CAGR during the forecast period due to the rapidly growing incidence of cardiovascular diseases. Refining healthcare infrastructure, increasing patient awareness, and rising healthcare expenditure levels in the region is expected to boost the investment by key market players in the region and hence anticipated to propel the market.

Rising prevalence of cardiac diseases along with introduction of novel technologically advanced electrophysiology devices and emphasis of companies to cater unmet needs are some of the major factors propelling the growth of the electrophysiology devices market during the forecast period.